Early Warning · Semiconductors · China-US

AXT plans Beijing indium-phosphide wafer expansion while U.S. approvals remain unresolved

AXT’s unresolved August approvals make the next filing window decisive for whether funded capacity becomes usable supply for U.S. buyers.

A blue semiconductor wafer with gold-colored patterned circuit dies rests on a black textured tray on a wooden surface.
A blue semiconductor wafer with gold-colored patterned circuit dies rests on a black textured tray on a wooden surface.Photo: JonathanMarks · CC BY-SA 4.0 · Wikimedia Commons

The order can be booked, the wafer can be made, and the customer can still be left waiting at the border. The delay sits between production and delivery.

The missing item is a Chinese export permit for indium-phosphide substrate: the wafer material used to make optical components. AXT’s Apr. 21 SEC filing and NTD’s report accessed Sept. 15 show the uncomfortable arrangement behind that wait. The California semiconductor-materials maker is raising money to expand indium-phosphide output at its Beijing subsidiary, while its ability to deliver abroad remains subject to approvals from the same country where that capacity sits.

AXT’s U.S.-bound shipments remain caught between permits and backlog.Permit status for Chinese-made indium-phosphide shipments to U.S. customers, China, March 2025 to Sept. 15; dates.
  1. March 2025AXT’s Chinese subsidiary began using the export-permit portal.
  2. 2025Permits were received for certain customers in Europe and Japan.
  3. Aug. 13AXT disclosed unresolved U.S. approvals and customer backlog.
  4. Sept. 15NTD reported that the U.S. approval timetable remained unresolved.
Source: NTD, China Export Curbs Delay AXT’s US-Bound Indium Phosphide Shipments, accessed Sept. 15 2026, Sept. 15, 2026
Show the data
Figure data: AXT’s U.S.-bound shipments remain caught between permits and backlog.
DateEvent
March 2025AXT’s Chinese subsidiary began using the export-permit portal.
2025Permits were received for certain customers in Europe and Japan.
Aug. 13AXT disclosed unresolved U.S. approvals and customer backlog.
Sept. 15NTD reported that the U.S. approval timetable remained unresolved.

A permit has therefore become part of the product, not a compliance detail after the sale.

NTD reported on Sept. 15 that AXT’s Chinese subsidiary began applying through an export-permit portal after it opened in March 2025. It received permits during 2025 for certain customers in Europe and Japan, but the company had not disclosed a timetable for approvals covering U.S. customers in its August filing.

That is the contradiction. Capacity expansion is being funded for a market in which shipment permission remains uncertain. A plant can add furnaces and staff; an exporter cannot load a controlled shipment until an authority has approved its application, NTD reported on Sept. 15.

NTD reported on Sept. 15 on the supply arrangement and this year’s backlog but did not establish which came first. AXT located the production expansion inside Beijing, and its Apr. 21 filing with the U.S. Securities and Exchange Commission says the new capital will financially support that subsidiary’s production effort. The filing says the capital is intended to support substrate expansion for worldwide export. The permit requirement creates the commercial consequence. Once a controlled product leaves that factory, the order still cannot move unless the required approval is granted.

Data-center construction may be bringing customers to AXT for more material. NTD reported on Sept. 15 that its account does not settle the size of either demand or licensing pressure. What it does establish is narrower and more useful: NTD reported that AXT identified permit approval, rather than factory output alone, as its principal obstacle to serving U.S. customers, while its applications remained unresolved in the August filing.

The earlier European and Japanese permits are an important limit on the larger claim, NTD reported on Sept. 15. They show that a control list does not amount to a blanket export ban, and they leave room for applications to be approved later. They also show why a simple count of announced capacity misses the live risk. The practical measure is capacity that can actually reach a specific destination after the license decision, not the substrate capacity written into a capital-spending plan.

This is a familiar weakness in supply-chain accounting. A buyer can record inventory, a producer can report output, and a public company can report a backlog. None of those figures tells a customer whether a controlled shipment has permission to cross a border. The public clue is the change in disclosed approvals and the status of shipments bound for American customers, not a general measure of demand for artificial-intelligence infrastructure.

The funded expansion at Beijing Tongmei Xtal Technology is a planned capacity response, not evidence that additional capacity is complete, qualified, or cleared for any particular destination, according to AXT’s Apr. 21 filing with the U.S. Securities and Exchange Commission. That distinction matters. A larger factory changes the amount that could be shipped. It does not change the approval status of an order already held at the export gate.

For a buyer that needs wafers for a production run, the pressure is measured in the interval between an approved order and a shipment. For a manufacturer expanding a substrate plant, the response is measured in construction, testing and customer approval. Those clocks do not run at the same speed.

The market exposure is therefore concentrated in optical-component supply chains tied to indium phosphide and in contracts dependent on Chinese-made substrate, as NTD reported on Sept. 15. The evidence does not show that all shipments have stopped, nor does it identify the inventory held by every downstream customer. It shows a narrower choke point. An unresolved permit can keep contracted material from becoming usable supply.

NTD reported on Sept. 15 that AXT’s August filing left the timetable for U.S. permits unresolved. AXT’s next filing will show whether it discloses permits covering U.S. customers and resumed shipments. If those permits are granted and shipments resume without AXT continuing to report that deliveries are constrained, the permit-centered explanation weakens and demand becomes the stronger explanation.

NTD reported on Sept. 15 that AXT’s August filing described unresolved approvals for American shipments and backlogged orders. If AXT’s filings continue to show those conditions, the permit remains the measure that matters.

A permit looks like paperwork only until a factory is waiting for the material it was meant to release to a U.S. customer.

What would change it. If AXT publicly discloses granted permits covering U.S. customers and resumed shipments while backlog persists, the permit-centered read breaks and end-user demand becomes the stronger explanation; NTD’s account of AXT’s Aug. 13 filing, accessed Sept. 15, left the approval timetable unresolved.

Sources

U.S. Securities and Exchange CommissionNTDBureau of Industry and Security

29 statements, each tied to its sourceWhat each statement rests onHow ARCANE checks a story

Sources
S1U.S. Securities and Exchange Commission, AXT Form 8-K, Apr. 21 2026: Established that AXT raised capital intended primarily to support Beijing Tongmei Xtal Technology’s indium-phosphide substrate expansion for worldwide export; it describes intended use of proceeds, not completed capacity or export approvals.Retrieved Sep 15, 2026
S2NTD, China Export Curbs Delay AXT’s US-Bound Indium Phosphide Shipments, accessed Sept. 15 2026: Reported on AXT’s Aug. 13 filing, unresolved U.S. permits, backlog, earlier permits for Europe and Japan, and downstream capacity agreements; it does not establish total industry inventory or the timing of future approvals.Retrieved Sep 15, 2026
S3Bureau of Industry and Security, Guidance & Frequently Asked Questions, accessed Sept. 15 2026: Established the U.S. government’s current public licensing framework and the separate role of licensing, exceptions, end-user and country controls; it does not govern China’s permit decisions.Retrieved Sep 15, 2026
ARCANE retrieved every source directly on 2026-09-16. Each claim was checked against those sources and reviewed automatically; no human editor has signed it.
All 3 sources were retrieved from their exact links, so a later change to any of them would be detectable
What each statement rests on (29)
inferredS1, S2

AXT plans Beijing indium-phosphide wafer expansion while U.S. approvals remain unresolved

inferredS1, S2

AXT’s unresolved August approvals make the next filing window decisive for whether funded capacity becomes usable supply for U.S. buyers.

inferredS1, S2

Early warning: A permit can preserve a contract on paper while leaving the downstream factory without usable supply, even as capacity expands in Beijing.

observedS1

Semiconductors

observedS2, S3

China-US

inferredS1, S2

The order can be booked, the wafer can be made, and the customer can still be left waiting at the border. The delay sits between production and delivery.

reportedS1, S2

The missing item is a Chinese export permit for indium-phosphide substrate: the wafer material used to make optical components. AXT’s Apr. 21 SEC filing and NTD’s report accessed Sept. 15 show the uncomfortable arrangement behind that wait. The California semiconductor-materials maker is raising money to expand indium-phosphide output at its Beijing subsidiary, while its ability to deliver abroad remains subject to approvals from the same country where that capacity sits.

inferredS2

A permit has therefore become part of the product, not a compliance detail after the sale.

reportedS2

NTD reported on Sept. 15 that AXT’s Chinese subsidiary began applying through an export-permit portal after it opened in March 2025. It received permits during 2025 for certain customers in Europe and Japan, but the company had not disclosed a timetable for approvals covering U.S. customers in its August filing.

inferredS1, S2

That is the contradiction. Capacity expansion is being funded for a market in which shipment permission remains uncertain. A plant can add furnaces and staff; an exporter cannot load a controlled shipment until an authority has approved its application, NTD reported on Sept. 15.

reportedS1, S2

NTD reported on Sept. 15 on the supply arrangement and this year’s backlog but did not establish which came first. AXT located the production expansion inside Beijing, and its Apr. 21 filing with the U.S. Securities and Exchange Commission says the new capital will financially support that subsidiary’s production effort. The filing says the capital is intended to support substrate expansion for worldwide export. The permit requirement creates the commercial consequence. Once a controlled product leaves that factory, the order still cannot move unless the required approval is granted.

reportedS2

Data-center construction may be bringing customers to AXT for more material. NTD reported on Sept. 15 that its account does not settle the size of either demand or licensing pressure. What it does establish is narrower and more useful: NTD reported that AXT identified permit approval, rather than factory output alone, as its principal obstacle to serving U.S. customers, while its applications remained unresolved in the August filing.

inferredS1, S2

The earlier European and Japanese permits are an important limit on the larger claim, NTD reported on Sept. 15. They show that a control list does not amount to a blanket export ban, and they leave room for applications to be approved later. They also show why a simple count of announced capacity misses the live risk. The practical measure is capacity that can actually reach a specific destination after the license decision, not the substrate capacity written into a capital-spending plan.

inferredS2, S3

This is a familiar weakness in supply-chain accounting. A buyer can record inventory, a producer can report output, and a public company can report a backlog. None of those figures tells a customer whether a controlled shipment has permission to cross a border. The public clue is the change in disclosed approvals and the status of shipments bound for American customers, not a general measure of demand for artificial-intelligence infrastructure.

reportedS1, S2

The funded expansion at Beijing Tongmei Xtal Technology is a planned capacity response, not evidence that additional capacity is complete, qualified, or cleared for any particular destination, according to AXT’s Apr. 21 filing with the U.S. Securities and Exchange Commission. That distinction matters. A larger factory changes the amount that could be shipped. It does not change the approval status of an order already held at the export gate.

inferredS1, S2

For a buyer that needs wafers for a production run, the pressure is measured in the interval between an approved order and a shipment. For a manufacturer expanding a substrate plant, the response is measured in construction, testing and customer approval. Those clocks do not run at the same speed.

reportedS2

The market exposure is therefore concentrated in optical-component supply chains tied to indium phosphide and in contracts dependent on Chinese-made substrate, as NTD reported on Sept. 15. The evidence does not show that all shipments have stopped, nor does it identify the inventory held by every downstream customer. It shows a narrower choke point. An unresolved permit can keep contracted material from becoming usable supply.

testableS2

NTD reported on Sept. 15 that AXT’s August filing left the timetable for U.S. permits unresolved. AXT’s next filing will show whether it discloses permits covering U.S. customers and resumed shipments. If those permits are granted and shipments resume without AXT continuing to report that deliveries are constrained, the permit-centered explanation weakens and demand becomes the stronger explanation.

testableS2

NTD reported on Sept. 15 that AXT’s August filing described unresolved approvals for American shipments and backlogged orders. If AXT’s filings continue to show those conditions, the permit remains the measure that matters.

inferredS2

A permit looks like paperwork only until a factory is waiting for the material it was meant to release to a U.S. customer.

inferredS1, S2

China’s export-permit process has turned indium-phosphide substrate capacity located in Beijing into uncertain usable supply for U.S. customers, even where commercial demand and production expansion are visible.

inferredS2

The less obvious exposure sits with downstream optical-component makers and customers whose supply agreements reserve AXT capacity but cannot guarantee that Chinese export approvals will accompany it.

inferredS2

The pressure points toward longer and less certain delivery schedules for indium-phosphide supply headed to U.S. customers while permit approvals remain unresolved.

reportedS2

AXT’s disclosed status of permits and shipments covering U.S. customers for indium-phosphide, together with its customer backlog, is the public measure reported from the company’s Aug. 13 filing by NTD on Sept. 15.

testableS2

The observation window is the next two quarterly filings, when AXT can disclose whether approvals and shipments to U.S. customers have changed.

testableS2, S3

A plant can add furnaces and staff; an exporter cannot load a controlled shipment until an authority has approved its application.

reportedS2

Watch whether AXT’s next public filing still describes unresolved Chinese approvals for shipments to U.S. customers of indium-phosphide alongside customer backlog; AXT’s Aug. 13 filing, reported by NTD in a report accessed Sept. 15, identified both conditions.

reportedS2

If AXT publicly discloses granted permits covering U.S. customers and resumed shipments while backlog persists, the permit-centered read breaks and end-user demand becomes the stronger explanation; NTD’s account of AXT’s Aug. 13 filing, accessed Sept. 15, left the approval timetable unresolved.

inferredS2

The pressure points toward indium-phosphide optical-component supply chains and contract commitments linked to Chinese-made substrate; the read fails if disclosed permit approvals restore shipments to U.S. customers without a continuing delivery constraint.

Alpha's read · open

China’s export-permit process has turned indium-phosphide substrate capacity located in Beijing into uncertain usable supply for U.S. customers, even where commercial demand and production expansion are visible.

Screen for this structure

Semiconductors · China-US

Open in screener